Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1771-1780 of 2933 for cancer

Edit search filters
  1. Tucatinib, Trastuzumab, Ramucirumab, And Paclitaxel Versus Paclitaxel And Ramucirumab In Previously Treated HER2+ Gastroesophageal Cancer

    Scottsdale/Phoenix, AZ

  2. ASCENT-Study Of Sacituzumab Govitecan In Refractory/Relapsed Triple-Negative Breast Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  3. (Z)-Endoxifen For The Treatment Of Premenopausal Women With ER+/HER2- Breast Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  4. Lower Or Standard Dose Regorafenib In Treating Patients With Refractory Metastatic Colorectal Cancer

    Scottsdale/Phoenix, AZ, Rochester, MN

  5. Study Of NXP900 With Osimertinib In Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  6. A Study To Evaluate HKI-272 And Capecitabine For HER2-Positive Breast Cancer And Brain Metastases

    Rochester, MN

  7. Safety And Immunogenicity Of PolyPEPI1018 Vaccine In The Treatment Of Metastatic Colorectal Cancer (OBERTO)

    Rochester, MN

  8. A Phase 2 Study Of VS-7375 In Patients With KRAS G12D-Mutated Pancreatic Cancer

    Jacksonville, FL, Rochester, MN

  9. A Study Of BBI608 Plus Weekly Paclitaxel To Treat Gastric And Gastro-Esophageal Junction Cancer

    Scottsdale/Phoenix, AZ

  10. Fat Emulsion In Preventing Hypersensitivity Reactions In Patients With Cancer Receiving Carboplatin Or Oxaliplatin

    Rochester, MN

.

Mayo Clinic Footer